Related Experiment Video
Updated: Feb 21, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Blueberry and malvidin inhibit cell cycle progression and induce mitochondrial-mediated apoptosis by abrogating the
Abdul Basit Baba1, Ramesh Nivetha1, Indranil Chattopadhyay2
1Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar-608 002, Tamil Nadu, India.
Abstract:
Blueberries, a rich source of anthocyanins have attracted considerable attention as functional foods that confer immense health benefits including anticancer properties. Herein, we assessed the potential of blueberry and its major constituent malvidin to target STAT-3, a potentially druggable oncogenic transcription factor with high therapeutic index. We demonstrate that blueberry abrogates the JAK/STAT-3 pathway and modulates downstream targets that influence cell proliferation and apoptosis in a hamster model of oral oncogenesis. Further, we provide mechanistic evidence that blueberry and malvidin function as STAT-3 inhibitors in the oral cancer cell line SCC131. Blueberry and malvidin suppressed STAT-3 phosphorylation and nuclear translocation thereby inducing cell cycle arrest and mitochondrial-mediated apoptosis. However, the combination of blueberry and malvidin with the STAT-3 inhibitor S3I-201 was more efficacious in STAT-3 inhibition relative to single agents. The present study has provided leads for the development of novel combinations of compounds that can serve as inhibitors of STAT-mediated oncogenic signalling.
Insights
Blueberries and malvidin inhibit the STAT-3 pathway, a key factor in oral cancer development. Combining them with other inhibitors enhances their anticancer effects, offering new therapeutic strategies.
Area of Science:
- Biochemistry
- Oncology
- Nutraceuticals
Background:
- Blueberries are rich in anthocyanins and recognized for health benefits, including anticancer properties.
- STAT-3 is an oncogenic transcription factor implicated in various cancers, making it a therapeutic target.
Purpose of the Study:
- To investigate the potential of blueberries and malvidin in targeting the JAK/STAT-3 pathway in oral cancer.
- To elucidate the mechanisms by which blueberry and malvidin exert anticancer effects.
Main Methods:
- Assessment of blueberry and malvidin effects on the JAK/STAT-3 pathway in a hamster model of oral oncogenesis.
- Mechanistic studies in the oral cancer cell line SCC131, including analysis of STAT-3 phosphorylation and nuclear translocation.
- Evaluation of combination therapy with blueberry, malvidin, and the STAT-3 inhibitor S3I-201.
Main Results:
- Blueberry abrogates the JAK/STAT-3 pathway and modulates downstream targets in oral oncogenesis.
- Blueberry and malvidin inhibit STAT-3 phosphorylation and nuclear translocation in oral cancer cells.
- Combination therapy with blueberry, malvidin, and S3I-201 showed enhanced STAT-3 inhibition.
Conclusions:
- Blueberry and its constituent malvidin act as STAT-3 inhibitors, inducing cell cycle arrest and apoptosis.
- Combination of blueberry and malvidin with STAT-3 inhibitors presents a promising strategy for oral cancer therapy.
- This study provides a basis for developing novel STAT-3 signaling inhibitors for cancer treatment.
Related Concept Videos
Inhibition of Cdk Activity
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
Drugs that Stabilize Microtubules
Abnormal Proliferation
Drugs that Destabilize Microtubules

